HTCD 2012
Cardiovascular diseases are the leading cause of death and disability in people over 50 years. There is an urgent need for physicians who are engaged in the conduct and treatment of patients with cardiovascular disease, in obtaining continuing medical education in this area.
During the Annual International Conference of Hybrid Surgery will be presented the most current information about new developments in clinical practice and relevant research, innovative technologies in surgical, endovascular, radiological, pharmacological treatments, along with discussions on when these procedures are justified, and when they are not. Update on clinical trials and the latest data, as well as opportunities for dialogue with experts in the cardiovascular field give an idea of the results of different treatments. In the framework of the sessions will be demonstrated relevance of hybrid endovascular and surgical treatment approaches in difficult patients during live cases broadcasts from the operating rooms and cathlabs.
Targets set for
- Provide information and share experience on new developments in treatment of cardiac valvular disease
- Provide information and share experience on the latest technologies, methods and clinical trials of endovascular treatment of thoracic and abdominal aortic pathology
- Provide information on the latest data, methods and technologies for the treatment of carotid artery disease
- Provide information about the latest news and share experience in the treatment of coronary artery disease
- Provide information about the latest developments in the treatment of patients with multistage vascular lesions
- Provide information on the latest developments in the pharmaceutical treatment of cardio-vascular diseases
